[HTML][HTML] Novel receptor tyrosine kinase pathway inhibitors for targeted radionuclide therapy of glioblastoma
J Bolcaen, S Nair, CHS Driver, TMG Boshomane… - Pharmaceuticals, 2021 - mdpi.com
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen, C Vandevoorde, S Nair, CHS Driver… - indico.tlabs.ac.za
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. The median survival is approximately 14 months and less than …
and treatment resistance. The median survival is approximately 14 months and less than …
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen, S Nair, CHS Driver… - …, 2021 - search.proquest.com
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.
J Bolcaen, S Nair, CHS Driver… - Pharmaceuticals …, 2021 - europepmc.org
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
[引用][C] 1. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen - spandidos-publications.com
[PDF][PDF] Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen, S Nair, CHS Driver… - …, 2021 - pdfs.semanticscholar.org
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.
J Bolcaen, S Nair, CHS Driver… - Pharmaceuticals …, 2021 - search.ebscohost.com
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen, S Nair, CHS Driver… - Pharmaceuticals …, 2021 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
[HTML][HTML] Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
J Bolcaen, S Nair, CHS Driver, TMG Boshomane… - …, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
Novel receptor tyrosine kinase pathway inhibitors for targeted radionuclide therapy of glioblastoma
J Bolcaen, S Nair, CHS Driver, C Vandevoorde… - 2021 - repository.up.ac.za
Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …